Twist Bioscience Corporation
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Other eventsAug 19 →InsidersNo open-market buys. 9 insiders sold $26.1M, 31 of 108 sales on a 10b5-1 plan.→HoldersBlackRock 9.3%Artisan Partners Limited Partnership 7.7%FMR 7.5%→Financing →PeersClosest companies: CDXS, LAB, DNA→
From the filings
Figures
- Revenue
- $431.8Mlast 12 months
- Net income
- −$136.7Mlast 12 months
- Operating cash flow
- −$55.6Mlast 12 months
- Cash and equivalents
- $117.4Mat the last balance sheet
- Shares outstanding
- 62.7M shareson issue